Author: Mark McCord

A consequence of a slowing US pension risk transfer market this year is that more insurers are bidding on more deals.

Increased competition for defined benefit pension schemes’ de-risking business in the UK has resulted in many insurers offering value-added incentives to better attract trustees and sponsors.

Run-on options for schemes small and large set to become real consideration for UK defined benefit pension sponsors.

Continued improvements in organ transplant techniques and procedures are increasing the success rate and post-operation life expectancy.

Pension Schemes Act will codify the operating rules and expectations of superfunds in the UK’s pensions industry.

Multiple reasons exist as to why biohacking is unlikely to impact mortality curves.

PRTs in the Netherlands have been steadily increasing since the government passed the Futures of Pensions Act.

New Prudential Regulation Authority consultation paper spells out the new capital charge for funded reinsurance deals.

Business may be brisk in the UK pension risk transfer market, but human capital constraints mean lower activity than is potentially possible.

Industry continues to model the potential upside of a successful rollout of MCED technology despite its newness.